IntrinsicIntrinsic
← Scroll for more →

Financial Statements — SCNX

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Cash & Equivalents8.19--6.66------------3.500.150.030.751.191.130.320.961.873.123.57
Accounts Receivable0.390.720.730.59--0.000.010.010.010.010.820.850.800.710.730.851.021.040.981.01
Inventory0.200.210.210.23------0.010.010.010.003.030.160.130.120.080.130.270.060.09
Total Current Assets9.204.777.921.420.867.836.317.2612.1414.032.755.552.102.392.092.373.353.604.375.19
Property, Plant & Equipment0.010.020.020.020.020.020.020.020.010.010.280.290.060.060.070.070.070.070.100.01
Goodwill------21.3721.3721.3721.377.85------5.13----0.00----------
Intangible Assets70.0770.5270.9776.4076.4076.4076.4076.40--8.968.969.45----0.79----0.79----
Total Non-current Assets*78.5375.8976.26103.41103.4498.5398.5587.002.702.719.7816.111.651.651.622.322.332.241.390.32
Total Assets87.7380.6684.18104.83104.29106.36104.8594.2614.8516.7412.5321.653.744.043.714.695.675.845.775.51
Accounts Payable0.921.401.443.673.143.182.902.900.730.952.081.330.860.520.730.741.200.910.480.28
Total Current Liabilities3.032.802.747.357.697.467.915.412.902.9511.569.094.262.552.152.062.551.600.930.65
Long-term Debt------2.003.583.092.90--------------------------
Total Non-current Liabilities*20.6111.0411.3214.8118.7517.7317.873.710.160.170.431.000.780.831.221.271.321.361.070.24
Total Liabilities23.6313.8414.0622.1626.4325.2025.789.133.063.1211.9910.095.043.383.373.333.872.952.000.90
Retained Earnings(86.78)(83.95)(80.55)(52.43)(48.82)(42.10)(39.04)(31.88)(26.50)(24.67)(33.25)(21.53)(21.88)(19.91)(19.72)(18.79)(18.29)(17.21)(16.25)(15.46)
Total Stockholder Equity64.1066.8270.1282.6777.8681.1679.0785.1311.7913.620.5411.56(1.29)0.660.761.401.822.873.774.62
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Total Revenue0.340.06(0.17)0.590.000.010.050.060.022.251.722.062.252.252.532.403.283.242.392.55
Cost of Revenue0.010.000.080.020.000.010.050.060.02--4.020.350.610.690.991.002.111.901.151.27
Gross Profit0.340.05(0.24)0.570.000.000.000.00-0.00--(2.31)1.701.641.561.541.401.171.341.241.28
Research & Development1.170.790.370.170.840.570.981.25------------------------
Selling, General & Admin0.371.071.482.172.931.361.390.170.424.701.490.610.300.380.270.290.550.652.022.58
Total Operating Expenses3.043.5629.264.945.163.574.213.501.495.503.422.551.991.903.491.812.272.302.025.78
Operating Income(2.70)(3.51)(29.50)(4.36)(5.16)(3.57)(4.21)(3.50)(1.50)(5.50)(5.73)(0.85)(0.35)(0.35)(1.95)(0.41)(1.10)(0.97)(0.78)(1.30)
Interest Expense------------------0.100.700.250.180.060.200.130.010.000.000.01
Pretax Income----(30.12)(3.61)(6.72)(3.06)(7.34)--------------------------
Net Income(2.82)(3.40)(28.12)(3.61)(6.72)(3.06)(7.16)(3.18)(1.83)21.25(11.67)(3.53)(1.97)(0.68)(0.93)(0.50)(1.08)(0.96)(0.78)(1.30)
Basic EPS(0.07)(0.08)(42.50)(0.19)(0.48)(0.33)(379.00)(1.34)(1.30)20.49(395.25)(4.57)(2.90)(0.07)(2.50)(0.06)(0.13)(0.12)----
Diluted EPS(0.07)(0.08)(42.50)(0.19)(0.48)(0.33)(291.25)(1.34)(1.30)16.77(120.75)(1.49)(2.90)--(2.50)(0.06)(0.13)(0.12)----
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow(3.13)(2.92)(5.18)(3.21)(2.03)(2.96)(2.91)(5.39)4.22(10.19)(0.98)(0.60)0.33(0.93)1.23(0.58)(1.18)(1.00)(0.43)(0.74)
Capital Expenditures------------0.000.01--------------------0.010.00
Free Cash Flow*------------(2.91)(5.40)--------------------(0.44)(0.74)
Investing Cash Flow------------0.000.12-0.0027.43--(0.21)(0.05)0.33(0.11)(0.06)(0.28)0.02----
Financing Cash Flow10.79(0.20)11.483.550.004.702.79(1.87)0.00(13.90)--0.11(0.73)0.68(0.30)(0.01)0.55(0.27)0.00(0.21)
← Scroll for more columns →

* Derived from reported values